Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"

Phase 4 Completed 875 enrolled Viatris Inc.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To determine whether "continuous use" of celecoxib over a 6-month period is more efficacious than "usual or intermittent use" in preventing spontaneous osteoarthritis flares of the knee and hip.

Timeline

Start: 2005-07
Primary completion: 2008-02
Completion: 2008-02

Publications

Strand V, Simon LS, Dougados M, Sands GH, Bhadra P, Breazna A, Immitt J. Treatment of osteoarthritis with continuous versus intermittent celecoxib. J Rheumatol. 2011 Dec;38(12):2625-34. doi: 10.3899/jrheum.110636. Epub 2011 Nov 1.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Celecoxib	Other / unclassified	200 mg	—

Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"

Summary

Timeline

Publications

Drugs

Indications